Volume 31, Issue 205 (2-2022)
J Mazandaran Univ Med Sci 2022, 31(205): 81-88 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kuhestani S, Shokrzadeh M, Aghajanshakeri S, Shokrzadeh S. Protective Effects of Simvastatin on Cytotoxicity and Oxidative Stress in Human Gingival Fibroblasts Cells Exposed to Venlafaxine. J Mazandaran Univ Med Sci 2022; 31 (205) :81-88
URL: http://jmums.mazums.ac.ir/article-1-17085-en.html
URL: http://jmums.mazums.ac.ir/article-1-17085-en.html
Abstract: (1016 Views)
Background and purpose: Venlafaxine is an antidepressant that belongs to the family of selective serotonin and norepinephrine reuptake inhibitor (SNRIs) drugs. Recent studies have indicated that prolonged use of antidepressants leads to a state where increased formation of reactive oxygen species (ROS) overwhelms body antioxidant protection and subsequently induces DNA damage, lipid peroxidation, protein modification and cytotoxicity. This study attempts to examine the protective effect of simvastatin against venlafaxine induced cytotoxicity and oxidative stress in human gingival fibroblasts (HGF) cells.
Materials and methods: In this experimental study, the intracellular ROS generation and IC50 were measured in cells treated with venlafaxine and simvastatin at different concentrations (50, 100, 150, and 200 μM) in pre-treatment in vitro condition.
Results: According to findings, HGF cell viability was significantly different in 150, and 200 μM of simvastatin compared with venlafaxine (P<0.01). Also, simvastatin significantly decreased the effects of venlafaxine by reducing the level of ROS at 150 and 200 μM (P<0.01).
Conclusion: This study suggests that simvastatin attenuates venlafaxine-induced cytotoxicity in HGF cells through scavenging excessive ROS.
Materials and methods: In this experimental study, the intracellular ROS generation and IC50 were measured in cells treated with venlafaxine and simvastatin at different concentrations (50, 100, 150, and 200 μM) in pre-treatment in vitro condition.
Results: According to findings, HGF cell viability was significantly different in 150, and 200 μM of simvastatin compared with venlafaxine (P<0.01). Also, simvastatin significantly decreased the effects of venlafaxine by reducing the level of ROS at 150 and 200 μM (P<0.01).
Conclusion: This study suggests that simvastatin attenuates venlafaxine-induced cytotoxicity in HGF cells through scavenging excessive ROS.
Type of Study: Brief Report |
Subject:
toxicology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
